precision medicine

Conference Coverage

American Society of Clinical Oncology (ASCO) 2017 Annual Meeting

05/16/2017

The ASCO Annual Meeting is undoubtedly the premier gathering of oncology professionals from the United States and abroad, and a fertile ground for the presentation of scientific advances throughout the field. More...

The...

05/16/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Effective in Treating Chemo-Resistant Ovarian Cancer

05/09/2017

JCP Editors

A combination regimen involving standard carboplatin chemotherapy and a novel drug may improve overall survival for more than 50% of women with high-grade serous ovarian cancers, according to research published in...

A...

05/09/2017

Journal of Clinical Pathways

Research in Review

Genomic Analyses Guide Targeted Therapies for Metastatic Cancers

04/07/2017

JCP Editors

High-throughput genomic analyses may improve outcomes in patients with types of metastatic cancer, according to results of a recent trial published in Cancer Discovery (published online April 1, 2017;...

...

04/07/2017

Journal of Clinical Pathways

Interview

Clinical Pathways, Targeted Therapies Likely to Shape Future MZL Treatment

03/23/2017

JCP Editors

Journal of Clinical Pathways spoke with Peter Martin, MD, Lymphoma Service Chief, Weill Cornell Medicine and New York-Presbyterian, about the role of targeted therapies and clinical pathways in...

...

03/23/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Efficacy of B-Cell Lymphoma Treatment

03/20/2017

JCP Editors

Combining two treatment strategies for the treatment of B-cell lymphoma may be more effective than either strategy alone, according to a study published in Cell Reports (February 28,...

...

03/20/2017

Journal of Clinical Pathways

Research in Review

New Biomarker for Relapsed or Refractory MZL Identified

02/27/2017

JCP Editors

Patients with marginal zone lymphoma (MZL) who underwent prior therapy with an anti-CD20 antibody regimen may be treatable with a tyrosine kinase inhibitor approved for other blood cancers, according to research...

...

02/27/2017

Journal of Clinical Pathways

Research in Review

Circulating Tumor Cell Analysis Improves HCC Diagnosis

01/23/2017

JCP Editors

A RNA-based digital polymerase chain reaction (PCR) method for analyzing circulating tumor cells greatly improves accuracy in diagnosing hepatocellular carcinoma (HCC), according to a report published in...

A...

01/23/2017

Journal of Clinical Pathways

Research in Review

Precision Medicine Approach Effective in Evaluating Pediatric Brain Tumors

01/20/2017

JCP Editors

A combination of genomic assays could be an effective precision medicine approach for clinical diagnosis, prognosis, and treatment guidance of pediatric brain tumors, according to new research published in...

A...

01/20/2017

Journal of Clinical Pathways

Research in Review

Precision Medicine Increasingly Guides Decision-Making for Patients with Breast Cancer

12/29/2016

JCP Editors

Breast cancer serves as a model for using precision medicine to guide treatment decisions and improve patients’ quality of life, according to a presentation at the 2016 Lynn Sage Breast Cancer...

Breast...

12/29/2016

Journal of Clinical Pathways

Research in Review

TKI Drug Improves Survival in Metastatic Kidney Cancer

11/22/2016

JCP Editors

First-line therapy with cabozantinib was superior to standard of care sunitinib with respect to progression-free survival and objective response rate for patients with intermediate- or poor-risk metastatic renal cell...

...

11/22/2016

Journal of Clinical Pathways